RESUMEN

Kinetoplastid membrane protein-11 (KMP-11), a protein present in all kinetoplastid protozoa, is considered a potential candidate for a leishmaniasis vaccine. A suitable leishmaniasis vaccine candidate molecule must be expressed in amastigotes, the infective stage for mammals. However, the expression of KMP-11 in Leishmania amastigotes has been a subject of controversy. We evaluated the expression of this molecule in logarithmic and stationary growth phase promastigotes, as well as in amastigotes, of Leishmania amazonensis by immunoblotting, flow cytometry and immunocytochemistry, using a monoclonal antibody against KMP-11. We found that KMP-11 is present in promastigotes and amastigotes. In both stages, the protein was found in association with membrane structures (at the cell surface, flagellar pocket and intracellular vesicles). More importantly, its surface expression is higher in amastigotes than in promastigotes and increases during metacyclogenesis. The increased expression of KMP-11 in metacyclic promastigotes, and especially in amastigotes, indicates a role for this molecule in the parasite relationship with the mammalian host. The presence of this molecule in amastigotes is consistent with the previously demonstrated immunoprotective capacity of vaccine prototypes based on the KMP-11-coding gene and the presence of humoral and cellular immune responses to KMP-11 in Leishmania-infected humans and animals.

Asunto(s)

Leishmania mexicana/crecimiento & desarrollo , Proteínas de la Membrana/metabolismo , Proteínas Protozoarias/metabolismo , Animales , Western Blotting , Femenino , Citometría de Flujo , Inmunoquímica , Leishmania mexicana/química , Ratones , Ratones Endogámicos BALB C , Microscopía Electrónica

RESUMEN

A mycobacterial codon-optimized gene encoding the Sm14 antigen of Schistosoma mansoni was generated using oligonucleotide assembly. This synthetic gene enhanced approximately fourfold the protein expression level in recombinant Mycobacterium bovis Bacille Calmette-Guérin (rBCG) when compared to that obtained using the native gene in the same expression vector. Immunization of mice with rBCG expressing Sm14 via the synthetic gene induced specific cellular Th1-predominant immune responses, as determined by interferon-gamma production of Sm14-stimulated splenocytes, which were comparable to those recorded in animals immunized with an rBCG strain expressing the native gene. Administration of a single dose of the rBCG-Sm14 construct carrying the synthetic gene conferred protection against cercarial challenge in outbred Swiss mice, at a level equivalent to those provided by either a single dose of rBCG expressing the native gene or three doses of Escherichia coli-derived recombinant Sm14. Our data demonstrated that despite improving the level of antigen expression, the codon optimization strategy did not result in enhanced immunity or protection against cercarial S. mansoni challenge.

Asunto(s)

Vacuna BCG/inmunología , Proteínas de Transporte de Ácidos Grasos/farmacología , Expresión Génica/efectos de los fármacos , Proteínas del Helminto/farmacología , Schistosoma mansoni/química , Esquistosomiasis mansoni/prevención & control , Animales , Vacuna BCG/administración & dosificación , Codón/genética , Proteínas de Transporte de Ácidos Grasos/genética , Proteínas de Transporte de Ácidos Grasos/inmunología , Proteínas de Transporte de Ácidos Grasos/uso terapéutico , Proteínas del Helminto/genética , Proteínas del Helminto/inmunología , Proteínas del Helminto/uso terapéutico , Ratones , Ratones Endogámicos BALB C , Mycobacterium bovis/genética , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/inmunología , Proteínas Recombinantes de Fusión/farmacología , Schistosoma mansoni/genética , Vacunas de ADN/administración & dosificación , Vacunas de ADN/inmunología , Vacunas Sintéticas

RESUMEN

Humoral and cellular immune responses of mice inoculated with recombinant Mycobacterium bovis BCG expressing the MSP1a antigen of Anaplasma marginale were evaluated. The msp1a gene was amplified by PCR and cloned into the mycobacterial expression vectors pUS2000 and pMIP12. Immunization of isogenic BALB/c mice with the rBCG/pUS2000-msp1a construct induced significant seroconversion to MSP1a (p<0.001), which was 26 times above pre-immunization levels at day 63 post-initial immunization and which remained stable for the duration of the experiment (6 months). In contrast, rBCG/pMIP12-msp1a induced seroconversion at a level of 6 times above pre-immunization values, which peaked at day 63. Western blot analysis showed that sera derived from mice vaccinated with either rBCG construct recognized both native and recombinant forms of A. marginale MSP1a. In contrast to the humoral response data, immunization with rBCG/pMIP12-msp1a was found to induce a markedly stronger cellular response than that recorded for BCG/pUS2000-msp1a. These observations clearly demonstrated the immunogenicity of recombinant BCG expressing the MSP1a antigen and suggested that the immune responses were influenced by the level of antigen expression. The results of this research warrant studies of recombinant M. bovis BCG expressing MSP1a in cattle to test for protective antibody production for control of bovine anaplasmosis.

Asunto(s)

Vacuna BCG/inmunología , Proteínas de la Membrana Bacteriana Externa/inmunología , Mycobacterium bovis/inmunología , Anaplasma marginale , Animales , Formación de Anticuerpos/inmunología , Vacuna BCG/genética , Proteínas de la Membrana Bacteriana Externa/biosíntesis , Proteínas de la Membrana Bacteriana Externa/genética , Bovinos , Clonación Molecular , Femenino , Inmunidad Celular/inmunología , Ratones , Ratones Endogámicos BALB C , Mycobacterium bovis/genética

RESUMEN

Dengue is one of the most important arboviral diseases in humans, and although efforts over the last decades have dealt with the development of a vaccine, this vaccine is not available yet. In order to evaluate the potential of a DNA vaccine based on the non-structural 1 (NS1) protein against dengue virus (DENV), we constructed the pcTPANS1 plasmid which contains the secretory signal sequence derived from human tissue plasminogen activator (t-PA) fused to the full length of the DENV-2 NS1 gene. Results indicate that pcTPANS1 promotes correct expression of NS1 in eukaryotic cells and drives secretion of the recombinant protein to the surrounding medium in a dimeric form. Balb/c mice, intramuscularly inoculated with this plasmid, presented high levels of antibodies, recognizing mainly surface-exposed conformational epitopes present in the NS1 protein expressed by insect cells. Long-term antibody response was observed in animals 56 weeks after the first plasmid inoculation, and a rapid, efficient secondary response was observed after a DNA boost. Vaccinated animals were challenged against DENV-2 in two murine models, based on intracerebral (i.c.) and intraperitoneal (i.p.) virus inoculations, and in both cases, pcTPANS1-immunized mice were protected. Overall, these results provide further support for the use of such a plasmid in a possible approach for the development of a vaccine against DENV.

Asunto(s)

Virus del Dengue/inmunología , Plásmidos , Activador de Tejido Plasminógeno/genética , Vacunas de ADN/administración & dosificación , Proteínas no Estructurales Virales/genética , Vacunas Virales/administración & dosificación , Animales , Anticuerpos Antivirales/biosíntesis , Secuencia de Bases , Cartilla de ADN , Fusión Génica , Ratones , Vacunas de ADN/inmunología , Vacunas Virales/inmunología

RESUMEN

UNLABELLED: MamMiBase, the mammalian mitochondrial genome database, is a relational database of complete mitochondrial genome sequences of mammalian species. The database is useful for phylogenetic analysis, since it allows a ready retrieval of nucleotide and aminoacid individual alignments, in three different formats (NEXUS for PAUP program, for MEGA program and for PHYLIP program) of the 13 protein coding mitochondrial genes. The user may download the sequences that are useful for him/her based on their parameters values, such as sequence length, p-distances, base content, transition transversion ratio, gamma, which are also given by MamMiBase. A simple phylogenetic tree (neighbor-joining tree with Jukes Cantor distance) is also available for download, useful for parameter calculations and other simple tasks. AVAILABILITY: MamMiBase is available at http://www.mammibase.lncc.br

Asunto(s)

Mapeo Cromosómico/métodos , ADN Mitocondrial/clasificación , ADN Mitocondrial/genética , Bases de Datos de Ácidos Nucleicos , Filogenia , Alineación de Secuencia/métodos , Análisis de Secuencia de ADN/métodos , Interfaz Usuario-Computador , Internet

RESUMEN

Two recombinant Mycobacterium bovis BCG (rBCG) vaccine strains were developed for the expression of cytoplasmically located S1 subunit of pertussis toxin, with expression driven by the hsp60 promoter of M. bovis (rBCG/pPB10) or the pAN promoter of Mycobacterium paratuberculosis (rBCG/pPB12). Both strains showed stable expression of equivalent levels of recombinant S1 in vitro and induced long-term (up to 8 months) humoral immune responses in BALB/c mice, although these responses differed quantitatively and qualitatively. Specifically, rBCG/pPB12 induced markedly higher levels of IgG1 than did rBCG/pPB10, and mice immunized with the former strain developed specific long-term memory to S1, as indicated by the production of high levels of S1-specific IgG in response to a sublethal challenge with pertussis toxin 15 months after initial immunization. When considered in combination with previous studies, our data encourage further evaluation of rBCG as a potential means of developing a low-cost whooping cough vaccine based on defined antigens.

Asunto(s)

Anticuerpos Antibacterianos/sangre , Bordetella pertussis/inmunología , Inmunización , Inmunoglobulina G/sangre , Mycobacterium bovis/genética , Toxina del Pertussis/inmunología , Vacuna contra la Tos Ferina/inmunología , Tos Ferina/inmunología , Animales , Evaluación Preclínica de Medicamentos , Femenino , Memoria Inmunológica , Inyecciones Intraperitoneales , Ratones , Ratones Endogámicos BALB C , Mycobacterium avium subsp. paratuberculosis/genética , Vacuna contra la Tos Ferina/administración & dosificación , Regiones Promotoras Genéticas , Proteínas Recombinantes/genética , Vacunas Sintéticas/administración & dosificación , Vacunas Sintéticas/inmunología , Tos Ferina/sangre

RESUMEN

The Sm14 antigen of Schistosoma mansoni was cloned and expressed in Mycobacterium bovis BCG as a fusion with the Mycobacterium fortuitum beta-lactamase protein under the control of its promoter, pBlaF*; the protein was localized in the bacterial cell wall. The rBCG-Sm14 strain was shown to be relatively stable in cultured murine and bovine monocytes in terms of infectivity, bacterial persistence, and plasmid stability. The immunization of mice with rBCG-Sm14 showed no induction of anti-Sm14 antibodies; however, splenocytes of immunized mice released increased levels of gamma interferon upon stimulation with recombinant Sm14 (rSm14), indicating an induction of a Th1-predominant cellular response against Sm14. Mice immunized with one or two doses of rBCG-Sm14 and challenged with live S. mansoni cercaria showed a 48% reduction in worm burden, which was comparable to that obtained by immunization with three doses of rSm14 purified from Escherichia coli. The data presented here further enhance the status of Sm14 as a promising candidate antigen for the control of schistosomiasis and indicate that a one-dose regimen of rBCG-Sm14 could be considered a convenient means to overcome many of the practical problems associated with the successful implementation of a multiple-dose vaccine schedule in developing countries.

Asunto(s)

Proteínas Portadoras/inmunología , Proteínas del Helminto/inmunología , Proteínas de Transporte de Membrana , Mycobacterium bovis/genética , Schistosoma mansoni/inmunología , Esquistosomiasis mansoni/prevención & control , Vacunas de ADN/inmunología , Animales , Anticuerpos Antihelmínticos/sangre , Proteínas Portadoras/genética , Proteínas Portadoras/metabolismo , Bovinos , Células Cultivadas , Proteínas de Transporte de Ácidos Grasos , Femenino , Proteínas del Helminto/genética , Proteínas del Helminto/metabolismo , Interferón gamma/biosíntesis , Ratones , Ratones Endogámicos BALB C , Monocitos , Mycobacterium fortuitum/enzimología , Mycobacterium fortuitum/genética , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/inmunología , Proteínas Recombinantes de Fusión/metabolismo , Schistosoma mansoni/crecimiento & desarrollo , Schistosoma mansoni/patogenicidad , Esquistosomiasis mansoni/parasitología , Vacunas de ADN/administración & dosificación , beta-Lactamasas/genética , beta-Lactamasas/metabolismo

RESUMEN

Mycobacterium vaccae represents an alternative mycobacterial cloning host that has been largely overlooked to date. The main reason for this may be the reported non-transformability of this species, specifically the so-called Stanford strain (NCTC 11659), with expression vectors that use kanamycin resistance as a selection method. However, this strain can be transformed using hygromycin resistance as an alternative selectable phenotype. The present study has shown that in contrast to previous reports, M. vaccae (ATCC 15483) is capable of being transformed with a range of vectors encoding kanamycin resistance as the selectable marker. Thereafter, the expression of the lacZ reporter gene in M. vaccae, Mycobacterium bovis BCG and Mycobacterium smegmatis mc(2)155 was evaluated using a range of characterized mycobacterial promoter sequences (hsp60, hsp70, PAN, 18kDa and 16S rRNA) cloned in the same promoter probe vector. In general, the promoters showed similar levels of activity in the three species, demonstrating that existing expression systems can readily be employed with M. vaccae (ATCC 15483). This was further confirmed by the observation that M. vaccae was capable of stable, in vitro expression of recombinant S1 subunit of pertussis toxin at levels equivalent to those obtained with BCG and M. smegmatis. Analysis of structural and functional stability of a range of vectors demonstrated that the incidence of instability noted for M. vaccae was lower than that recorded for M. smegmatis. Taken together, the results indicate that M. vaccae is an additional cloning host which may prove useful for specific aspects of mycobacterial biology and provide increased flexibility to the field of recombinant protein technology for mycobacteria.

Asunto(s)

Vectores Genéticos , Mycobacterium/genética , Transformación Bacteriana , Secuencia de Bases , Clonación Molecular/métodos , Electroporación , Datos de Secuencia Molecular , Mycobacterium/clasificación , Toxina del Pertussis , Plásmidos , Regiones Promotoras Genéticas , Factores de Virulencia de Bordetella/genética , Factores de Virulencia de Bordetella/metabolismo